Development of ADC: Use of Model Systems for Understanding Mechanisms, Prioritization and Optimization of T-DXd and Combinations
Time: 1:30 pm
day: Applications for Efficacy Evaluation & Biomarker Discovery Day 2 PM
Details:
- Evaluating the pros and cons of in vitro and in vivo models to facilitate preclinical to clinical translation
- Improving the ability to predict the efficacy and toxicity of ADC combinations
- Using combination mechanisms to select model systems
